Targeting CD36: Modulating inflammation and atherogenesis David P. HajjarAntonio M. Gotto Jr. Invited Commentary Pages: 155 - 156
Targeting gene therapy vectors to the vascular endothelium Lorraine M. WorkStuart A. NicklinAndrew H. Baker OriginalPaper Pages: 163 - 170
Cell physiology as a variable in gene transfer to endothelium Philip L. Leopold OriginalPaper Pages: 171 - 177
Targeting signaling pathways in heart failure by gene transfer Briain D. MacNeillMotoya HayaseRoger J. Hajjar OriginalPaper Pages: 178 - 185
Applied gene therapy in preclinical models of vascular injury Stefan P. Janssens OriginalPaper Pages: 186 - 190
Targeting ischemic cardiac dysfunction through gene transfer Takashi MatsuiAnthony Rosenzweig OriginalPaper Pages: 191 - 195
Vascular failure: A hypothesis Stephen M. SchwartzRandolph L. GearyLawrence D. Adams OriginalPaper Pages: 201 - 207
Vascular smooth muscle diversity: Insights from developmental biology Mark W. Majesky OriginalPaper Pages: 208 - 213
New insights into endothelial diversity James E. TomlinsonJames N. Topper OriginalPaper Pages: 223 - 229
Stem cell origins of intimal cells in graft arterial disease Koichi ShimizuRichard N. Mitchell OriginalPaper Pages: 230 - 237